GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (WBO:SYAB) » Definitions » Common Stock

Synlab AG (WBO:SYAB) Common Stock : €222 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Synlab AG Common Stock?

Synlab AG's quarterly common stock stayed the same from Sep. 2023 (€222 Mil) to Dec. 2023 (€222 Mil) and stayed the same from Dec. 2023 (€222 Mil) to Mar. 2024 (€222 Mil).

Synlab AG's annual common stock stayed the same from Dec. 2021 (€222 Mil) to Dec. 2022 (€222 Mil) and stayed the same from Dec. 2022 (€222 Mil) to Dec. 2023 (€222 Mil).


Synlab AG Common Stock Historical Data

The historical data trend for Synlab AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG Common Stock Chart

Synlab AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Common Stock
134.39 222.22 222.22 222.22

Synlab AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 222.22 222.22 222.22 222.22 222.22

Synlab AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Synlab AG (WBO:SYAB) Business Description

Traded in Other Exchanges
Address
Moosacher Strasse 88, Augsburg, BY, DEU, 80809
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (WBO:SYAB) Headlines

No Headlines